BioStorage Technologies Inc.

BioStorage Technologies Inc. provides advanced sample management solutions that enhance laboratory efficiency through innovative storage systems and products tailored for biobanks and research institutions. BioStorage Technologies Inc. specializes in sample management solutions.

Founded in 2002 in Indianapolis, US, the company was sold to Brooks Automation on November 5, 2015, for USD 127 mn. The company has engaged in a total of 6 deals to date. The founder's background includes experience in laboratory management and technology. Azenta Life Sciences specializes in advanced sample management solutions, offering a range of products and services designed to enhance laboratory efficiency and streamline workflows.

Their core offerings include the BioArc Ultra automated storage system, which optimizes time, space, and energy costs for biobanks and laboratories. This system features broad compatibility, allowing users to maintain operational consistency without altering existing settings, and facilitates a one-handed operation for ease of use. Additionally, Azenta provides a comprehensive range of sample storage tubes that ensure sample integrity and improve tracking, tailored to various workflows in research and clinical settings. The company serves a diverse client base, including academic institutions, pharmaceutical companies, and clinical research organizations, primarily in markets such as North America, Europe, and Asia.

Azenta Life Sciences generates revenue through a combination of direct sales and service agreements, primarily leveraging its portfolio of automated storage solutions and laboratory information management systems (LIMS). The company engages in B2B transactions, providing its products and services to laboratories and biobanks, which may involve long-term contracts for supply and support. Their flagship products, including the BioArc Ultra and Limfinity LIMS, are integral to the workflow of clients, and the pricing structure reflects a tiered model based on the scale and complexity of the solutions implemented. The nature of these transactions indicates a focus on building sustained partnerships with clients, ensuring that their technological needs are met with ongoing support and integration into existing systems.

Future growth plans for BioStorage Technologies Inc. include the development of new products designed to enhance storage capabilities in research and clinical environments. The company aims to expand its market presence in Europe and Asia by 2025, capitalizing on the recent funding received from the Trade Sale valued at USD 127 mn. This funding will support the launch of new innovative solutions and the improvement of existing products to meet evolving client needs.